- Home
- CXAI vs RNXT Comparison
CXAI vs RNXT Comparison
Compare CXAI & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- RNXT
- Stock Information
- Founded
- CXAI N/A
- RNXT 2012
- Country
- CXAI United States
- RNXT United States
- Employees
- CXAI N/A
- RNXT N/A
- Industry
- CXAI EDP Services
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- RNXT Health Care
- Exchange
- CXAI Nasdaq
- RNXT Nasdaq
- Market Cap
- CXAI 33.9M
- RNXT 31.6M
- IPO Year
- CXAI N/A
- RNXT 2021
- Fundamental
- Price
- CXAI $1.50
- RNXT $1.03
- Analyst Decision
- CXAI
- RNXT Strong Buy
- Analyst Count
- CXAI 0
- RNXT 1
- Target Price
- CXAI N/A
- RNXT $9.00
- AVG Volume (30 Days)
- CXAI 613.3K
- RNXT 218.8K
- Earning Date
- CXAI 04-14-2025
- RNXT 03-31-2025
- Dividend Yield
- CXAI N/A
- RNXT N/A
- EPS Growth
- CXAI N/A
- RNXT N/A
- EPS
- CXAI N/A
- RNXT N/A
- Revenue
- CXAI $7,200,000.00
- RNXT N/A
- Revenue This Year
- CXAI $3.86
- RNXT N/A
- Revenue Next Year
- CXAI $100.00
- RNXT N/A
- P/E Ratio
- CXAI N/A
- RNXT N/A
- Revenue Growth
- CXAI N/A
- RNXT N/A
- 52 Week Low
- CXAI $1.09
- RNXT $0.77
- 52 Week High
- CXAI $7.07
- RNXT $1.86
- Technical
- Relative Strength Index (RSI)
- CXAI 41.74
- RNXT 35.37
- Support Level
- CXAI $1.46
- RNXT $1.00
- Resistance Level
- CXAI $1.69
- RNXT $1.18
- Average True Range (ATR)
- CXAI 0.10
- RNXT 0.10
- MACD
- CXAI 0.01
- RNXT -0.03
- Stochastic Oscillator
- CXAI 30.19
- RNXT 6.00
About CXAI CXApp Inc.
CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.